Skip to content

Releases: OpenOmics/chrom-seek

v1.2.0

07 Aug 18:08
27a0e29
Compare
Choose a tag to compare

What's Changed

  • Major refactor codebase by @rroutsong in #41
  • Added time stamp to slurm out and err logs by @rroutsong in #42
  • Removal of MEME and SICER due to issues in the previous version
  • UROPA now only runs protTSS option

New Contributors

Full Changelog: v1.1.0...v1.2.0

v1.1.0

07 Aug 17:57
Compare
Choose a tag to compare

What's Changed

Full Changelog: v1.0.2...v1.1.0

v1.0.0

13 Sep 15:27
Compare
Choose a tag to compare

chrom-seek (v1.0.0)

This is the first major release of the chrom-seek pipeline! chrom-seek is an awesome set of epigenetic pipelines designed to process and analyze paired-end cell-free ChIP-seq, ChIP-seq, and ATAC-seq data.

Contributors

A big thanks to the contributors who made this release possible:

Cite

If you use this software, please cite our methods paper:

BibText
@article {Jange202302003,
	author = {Moon Kyoo Jang and Tovah E Markowitz and Temesgen E Andargie and Zainab Apalara and Skyler Kuhn and Sean Agbor-Enoh},
	title = {Cell-free chromatin immunoprecipitation to detect molecular pathways in heart transplantation},
	volume = {6},
	number = {12},
	elocation-id = {e202302003},
	year = {2023},
	doi = {10.26508/lsa.202302003},
	publisher = {Life Science Alliance},
	abstract = {Existing monitoring approaches in heart transplantation lack the sensitivity to provide deep molecular assessments to guide management, or require endomyocardial biopsy, an invasive and blind procedure that lacks the precision to reliably obtain biopsy samples from diseased sites. This study examined plasma cell-free DNA chromatin immunoprecipitation sequencing (cfChIP-seq) as a noninvasive proxy to define molecular gene sets and sources of tissue injury in heart transplant patients. In healthy controls and in heart transplant patients, cfChIP-seq reliably detected housekeeping genes. cfChIP-seq identified differential gene signals of relevant immune and nonimmune molecular pathways that were predominantly down-regulated in immunosuppressed heart transplant patients compared with healthy controls. cfChIP-seq also identified cell-free DNA tissue sources. Compared with healthy controls, heart transplant patients demonstrated greater cell-free DNA from tissue types associated with heart transplant complications, including the heart, hematopoietic cells, lungs, liver, and vascular endothelium. cfChIP-seq may therefore be a reliable approach to profile dynamic assessments of molecular pathways and sources of tissue injury in heart transplant patients.},
	URL = {https://www.life-science-alliance.org/content/6/12/e202302003},
	eprint = {https://www.life-science-alliance.org/content/6/12/e202302003.full.pdf},
	journal = {Life Science Alliance}
}
APA
Jang, M. K., Markowitz, T. E., Andargie, T. E., Apalara, Z., Kuhn, S., & Agbor-Enoh, S. (2023). Cell-free chromatin immunoprecipitation to detect molecular pathways in heart transplantation. Life Science Alliance, 6(12), e202302003. https://doi.org/10.26508/lsa.202302003